ECE 2007 - Budapest, 28 April -2 May 2007

The 9th European Congress of Endocrinology is being hosted by the Hungarian Society of Endocrinology and Metabolism and will be held at Papp Lászlό Budapest Sportaréna, H-1143 Budapest, Stefánia út 2. Hungary from 28 April until 2 May 2007. Attendees are expected from all over the world to learn from the latest advances in endocrine research and clinical care presented by the thought leaders in the field. The POC has actively worked to put together a programme of scientific excellence that will be attractive to all professionals interested in endocrinology and metabolism. On-line registration form is available via the link below or for further information, visit www.ece2007.com. Please note the 15th European Congress on Obesity (ECO 2007) is also taking place in Budapest in the previous week, 22-25 April 2007. Please see the link below for more details

ECE 2007 Registration

ECO2007

E-Vote for Election to the ESE Executive Committee

Candidate information is available via the link below . Voting will be by e-vote only and is open from 1 March to 18 April 2007. Eligible voters will receive an email from the ESE with full instructions on how to vote.

Link to e-vote

2007 AGM notice of date and time

Notice is hereby given that the 2007 Annual General Meeting of the European Society of Endocrinology will be held at 18.30 on Tuesday 1 May 2007 in Plenary Lecture Hall, Papp Lászlo Budapest Sportaréna, H-1143 Budapest, Stefánia út 2. Hungary. To request a copy of the draft agenda please contact the ESE Secretariat on info@euro-endo.org.

Online Membership renewal now available

Your membership can now be renewed online. Before making payment you will need to obtain a password. Full instructions on how to obtain this will be detailed on the website here: link

Membership applications

All applications for Ordinary membership are formally approved by the ESE Executive Committee and by the full membership at the Annual General Meeting. The closing date for applications to be approved at the 2007 AGM has now passed. Applications received after the closing date will be approved at the 2008 AGM. Further details regarding membership and the application form can be found on the web link below.

Membership applications

ECE 2008

The 10th European Congress of Endocrinology will be hosted by the German Endocrine Society and will be held at the ICC in Berlin, 3 – 7 May 2008. The call for abstracts and registration is due to open in March 2007 – keep an eye on the website www.ece2008.com for further details.

http://www.ece2008.com/

Kickboxing 'causes brain damage' (BBC News, 28 March 2007)

New research has shown that kickboxing can cause damage to the pituitary, resulting in decreased production of hormones.

Full article

Spain enacts anti-doping law (Sports Illustrated, 23 February 2007)

New legislation imposing jail sentences on anyone inciting doping in sports came into force in Spain on Friday, along with the creation of a national anti-doping agency.

Link

Europe wants drugs ban extension

European Athletics wants to ban athletes found guilty of doping offences from competing at major championships for a further two years.

Full article

Glucose tolerance under unboosted atazanavir treatment

Treatment of HIV using antiretroviral drugs often results in metabolic disturbances. The protease inhibitor atazanavir has a less pronounced effect on the GLUT4 transporter and is characterised by a favourable lipid profile. In this study, Guffanti et al investigate what effect switching to unboosted atazanavir for 24 weeks has upon the oral glucose tolerance of patients whose current HIV treatment has caused metabolic disturbances. Twenty-one patients were included for analysis, with a median of 6.42 years previous exposure to antiretroviral therapy. The metabolic analysis included fasting plasma glucose, serum insulin, C-peptide, triglycerides and cholesterol; CD4+ cell count and HIV-RNA were assessed. Measurements were taken at baseline and weeks 4, 12 and 24. The homeostasis model assessment of insulin sensitivity and β-cell function showed no significant change after unboosted atazanavir treatment, though there were small changes in favourable directions for each. The group identified a significant improvement in lipid profiles when comparing baseline to week 24 measurements; the 120-min glucose level and an OGTT-based index of insulin sensitivity were also reduced significantly. There were few adverse events associated with the treatment and HIV replication was effectively controlled. The study concludes that unboosted atazanavir can have favourable effects on metabolic parameters compared to other PIs. They identify a need for randomised studies in a larger patient group over a longer period of time. Monica Guffanti, Andrea Caumo, Laura Galli, Alba Bigoloni, Andrea Galli, Geneviéve Dagba, Anna Danise, Livio Luzi, Adriano Lazzarin and Antonella Castagna. Switching to unboosted atazanavir improves glucose tolerance in highly pretreated HIV-1 infected subjects. European Journal of Endocrinology 2007 156 503-509.

EMBO Installation Grants

Apply for an EMBO Installation Grant to set up your research group in: Croatia, the Czech Republic, Estonia, Poland, Portugal or Turkey. Successful applicants will receive €50,000 annually for 3-5 years and benefit from a range of networking and career development support. Annual application deadline: 15 April 2007

Link to EMBO Grants

Studies on the Management of Diabetes and Blood Glucose Abnormalities, European Foundation for the Study of Diabetes

Via www.RDFunding.org. An EFSD/Sanofi-aventis European Programme for the Funding of Studies on the Management of Diabetes and Blood Glucose Abnormalities in Patients with Cardiovascular Disease. Applications from studies measuring parameters of blood glucose control, cardiac function, endothelial function, lipid metabolism or evaluating microvascular complications in patients with a chronic cardiovascular disease, or experiencing an acute cardiovascular event, before and after insulin treatment compared to other treatments, or comparing different insulin treatment regimens, will be specially considered. Full details can be found on the RDFunding website, link below. Closing date: 15 January 2008.

Full details

Specialist Physician in Urology or Endocrinology

Department of Urology, San Paolo University, Italy. The department deals with male infertility and all male genital pathologies - erectile dysfunction and other sexual disorders included - both medically and surgically. It includes a Seminology Laboratory with annexed Semen Bank and an Embryology Laboratory. All this is integrated into an Infertility Center with a Section for Assisted Reproductive Technology. Prerequisites for the job: Previous clinical experience in the above-mentioned areas, English Language, citizenship of a European Community member country. Optional, preferential requirements: Experience in ultrasonographic diagnosis of the male genital apparatus, at least partial knowledge of the Italian language. Applicants should send their CVs to the following e-mail addresses: gpiediferro@libero.it and gmcolpi@yahoo.com. Further information about the department and the Head Physician, (search for Giovanni Colpi), can be found via the links below.

University

Head Physician

International Medical Affairs Manager, HRA Pharma, Paris, France

Language needed: English. Area: Niche products/ Orphan drugs in Endocrinology. The medical affairs manager will be the internal expert for the existing portfolio and for future projects in the field. International Key Opinion Leaders management. Transversal activity, interaction with R&D, regulatory, pharmacovigilance & marketing departments. The profile is for a physician ideally specialised in endocrinology. First experience (either clinical or industrial) would be appreciated. For more information contact: François Vuillet at Laboratoire HRA Pharma, 15 rue Béranger 75003 PARIS, France. Phone: 00 33 1 40 33 11 30. Fax : 00 33 1 42 77 18 83. Email : f.vuillet@hra-pharma.com or visit the website below.

Website

If you have any feedback on the content of the alert, email: mailto:jo.thurston@endocrinology.org%20

Please feel free to pass this email alert on to anyone you think may be interested.